Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Tetra Bio-Pharma Inc. (C:TBP)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 2742 St. Joseph Blvd Unit 200
Tel: 1-646-2550433
IR: See website
Key People
William M. Cheliak
Independent Chairman of the Board
Chris MacLean
Chief Operating Officer of Tetra Natural Health and Panag
Sylvain Chretien
Guy Chamberland
Chief Executive Officer, Director, Chief Regulatory Officer
Jean-Francois Boily
Chief Financial Officer
Graham Keith Wood
Chief Operating Officer
Robert Bechard
Executive Vice President - Corporate Development and Licensing
Richard Giguere
Executive Vice President - Commercial Operations
Dania Scott
Senior Vice President - Commercial Strategy
Melanie Kelly
Chief Scientific Officer
Business Overview
Tetra Bio Pharma Inc is a Canada-based company engaged in the development of bio pharmaceuticals and natural health products containing cannabis and other medicinal plant based elements. The Company is focused on combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators physicians and insurance companies. The Company objective is to bring smokable, natural medical marijuana to the market along with a number of other products targeting chronic pain, insomnia, post-traumatic stress disorder (PTSD), anxiety, among others. The Company operates through three divisions: PhytoPain Pharma Inc, Agro Tek Health and Grow Pros Cannabis Ventures Inc.
Financial Overview
For the three months ended 28 February 2021, TetraBio Pharma Inc revenues was not reported. Net loss beforeextraordinary items increased 84% to C$8.3M. Higher netloss reflects Research and development increase from C$1.7Mto C$4.1M (expense), General and administrative increasefrom C$210K to C$1.7M (expense), Professional fees increasefrom C$334K to C$1.3M (expense).
Employees: 33 as of Nov 30, 2020
Reporting Currency: Canadian Dollars
Enterprise value: $165.31M as of Feb 28, 2021
Annual revenue (TTM): $0.00M as of Feb 28, 2021
EBITDA (TTM): -$24.20M as of Feb 28, 2021
Net annual income (TTM): -$24.97M as of Feb 28, 2021
Free cash flow (TTM): -$22.37M as of Feb 28, 2021
Net Debt Last Fiscal Year: $1.94M as of Feb 28, 2021
Shares outstanding: 360,461,930 as of Mar 5, 2021
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization